image
Aileron Therapeutics, Inc. ALRN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.87
-13.3 %
$ 62.2 M
Market Cap
-0.93
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-16.3 M OPERATING INCOME
41.13%
Growth Rates
1Year 41.13%
3Years 7.40%
5Years 12.59%
7Years 1.56%
10Years -19.54%
-15.7 M NET INCOME
42.43%
Growth Rates
1Year 42.43%
3Years 9.40%
5Years 12.99%
7Years 2.00%
10Years -19.18%
EFFICIENCY
Earnings Waterfall Aileron Therapeutics, Inc.
image
Revenue 0
Cost Of Revenue 119 K
Gross Profit -119 K
Operating Expenses 16.3 M
Operating Income -16.3 M
Other Expenses -544 K
Net Income -15.7 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 0 0 0 0 0 0 0 0 0 0 22.4
GROSS PROFIT
Cost Of Revenue 0.1 0.2 0.1 0.2 0.2 0.2 95 K 0.2 0.3 9.3 12.2
Gross Profit (0.1) (0.2) (0.1) (0.2) (0.2) (0.2) 95 K (0.2) (0.3) (9.3) 10.1
OPERATING INCOME
Operating Expenses 16.3 27.6 26.6 20.5 30.0 31.9 23.0 18.2 12.9 6.7 6.8
Selling, General and Administrative Expenses 11.4 9.7 9.6 9.3 12.3 13.5 8.8 7.9 5.1 6.7 6.8
Research and Development Expenses 4.0 18.0 17.0 11.2 17.7 18.4 14.2 10.3 7.8 9.3 12.2
Operating Income (16.3) (27.6) (26.6) (20.5) (30.0) (31.9) (23.0) (18.2) (12.9) (16.0) 3.3
PRE-TAX INCOME
Interest Income Expense 0 (0.3) 0 0 0 0 0 0 0 0 0
Total Other Income 0.5 0.3 0.4 (0.7) 0.6 0.4 0.4 46 K 13 K 10 K 6 K
Pre-Tax Income (15.7) (27.3) (26.2) (21.2) (29.4) (31.5) (22.6) (18.1) (12.9) (16.0) 3.3
NET INCOME
Tax Provision 0 (0.3) (0.4) 0.7 (0.6) 0.4 34 K 0 0 43 K 3.1
Net Income (15.7) (27.0) (25.8) (21.8) (28.8) (31.5) (22.6) (18.1) (12.9) (16.1) 0.2
EPS 3.42 5.95 5.8 12.5 23.5 42.8 60.7 33.2 23.6 846 10.2